(1)
Studying Obesity-Associated Changes in White Blood Cell Count (WBCs) and in Some WBC-Derived Inflammatory Markers in Type 2 Diabetic Patients under Treatment With Metformin Monotherapy. Tuj-hlth 2024, 46 (3), 87-100.